Clinical Trial News and Research

RSS

First therapy indicated for treating adults with rare blood clotting disorder receives FDA approval

The U.S. Food and Drug Administration today approved Cablivi (caplacizumab-yhdp) injection, the first therapy specifically indicated, in combination with plasma exchange and immunosuppressive therapy, for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), a rare and life-threatening disorder that causes blood clotting.

7 Feb 2019

HEROES awarded two grants to support opioid intervention program in Houston

The Houston Emergency Response Opioid Engagement System was recently awarded two grants that will help fund the opioid intervention program through the end of 2020.

6 Feb 2019

Novel lysin therapy shows promise for fighting drug-resistant bacteria

Humans are in a constant arms race with infectious bacteria. To kill these disease microbes, we develop powerful antibiotics; and in turn, the bacteria develop resistance against these drugs.

5 Feb 2019

Researchers move a step closer to developing new pneumonia vaccine

A vaccine against the biggest bacterial killer on the planet is a step closer to being available with funding secured for preclinical trials.

4 Feb 2019

New research uncovers crucial link between polyamines and MYCN

The MYCN oncogene has long been known to be a key cause of a number of deadly solid tumor cancers, including neuroblastoma, which claims more lives of children under the age of 5 than any other cancer.

4 Feb 2019

Spinal cord stimulation can restore voluntary movement and autonomic functions in paralyzed patients

There are more than 290,000 people estimated to be living in the United States with a spinal cord injury. Previously, it has been shown that it is possible to restore some function to young and healthy patients within a few years of injury.

1 Feb 2019

Frail seniors find ways to live independently

Pauline Jeffery had let things slide since her husband died. Her bedroom was a mess. Her bathroom was disorganized. She often tripped over rugs in her living and dining room.

31 Jan 2019

New apprenticeship scheme set to support Life Sciences Industrial Strategy of the UK government

Approval has been granted for the development of a new national apprenticeship standard for the role of clinical pharmacology scientist, thanks to a cross-sector drive to address the skills gap.

31 Jan 2019

New guidelines developed for effective management of neuropsychiatric symptoms of Huntington’s disease

Although Huntington's disease (HD) is traditionally thought of as a neurological disorder, behavioral symptoms are a common feature and frequently cause distress and difficulty to patients, family members, and other caregivers.

30 Jan 2019

E-cigarettes are almost twice as effective as nicotine replacement treatments, shows new study

E-cigarettes are almost twice as effective as nicotine replacement treatments, such as patches and gum, at helping smokers to quit, according to a clinical trial led by Queen Mary University of London.

30 Jan 2019

New adaptive treatment strategy increases the benefits of Internet-delivered CBT

Scientists at Karolinska Institutet have experimented with a new adaptive treatment strategy for Internet-delivered cognitive behavioral therapy that identifies patients within the first month who face a major risk of treatment failure.

30 Jan 2019

First precision medicine trial in lung cancer expands to include more patients

The Lung Cancer Master Protocol, the first precision medicine trial in lung cancer supported by the National Cancer Institute, part of the National Institutes of Health, is undergoing a major expansion to include patients with all non-small cell lung cancers -- which make up about 85 percent of all lung cancer diagnoses in the U.S.

29 Jan 2019

People with sight problems could benefit from new surgical trial

People with sight problems could benefit from a surgical trial advance that has been shown to help restore the surface of the eye.

29 Jan 2019

Alzheimer's Association grants more than $800,000 to support the SPRINT MIND Study

The Alzheimer's Association has awarded more than $800,000 to support the SPRINT MIND 2.0 Study, which will further investigate the impact of intensive blood pressure treatment on reducing risk of dementia.

29 Jan 2019

NIAID-funded clinical trial of Ebola vaccines is underway at Cincinnati Children's

A Phase 1 clinical trial of investigational vaccines intended to protect against Zaire ebolavirus (Ebola) is underway at Cincinnati Children's Hospital Medical Center in the United States. The study is sponsored by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

28 Jan 2019

UTHealth enrolls first U.S. patient in novel stem cell trial to treat stroke disability

The first U.S. patient to participate in a global study of a stem cell therapy injected directly into the brain to treat stroke disability was enrolled in the clinical trial this week at The University of Texas Health Science Center at Houston.

28 Jan 2019

Injection of genetically modified virus effectively treats metastatic melanoma patients

Injection of a genetically modified virus that induces the body's own immune cells to attack metastatic melanoma effectively treated almost 40 percent of patients with tumors that could not be surgically removed, according to researchers from three prominent cancer centers in a study published as an "article in press" on the Journal of the American College of Surgeons website in advance of print publication.

28 Jan 2019

Clinical Trial News and Research

First therapy indicated for treating adults with rare blood clotting disorder receives FDA approval

HEROES awarded two grants to support opioid intervention program in Houston

Novel lysin therapy shows promise for fighting drug-resistant bacteria

Researchers move a step closer to developing new pneumonia vaccine

New research uncovers crucial link between polyamines and MYCN

Spinal cord stimulation can restore voluntary movement and autonomic functions in paralyzed patients

Frail seniors find ways to live independently

New apprenticeship scheme set to support Life Sciences Industrial Strategy of the UK government

New guidelines developed for effective management of neuropsychiatric symptoms of Huntington’s disease

E-cigarettes are almost twice as effective as nicotine replacement treatments, shows new study

New adaptive treatment strategy increases the benefits of Internet-delivered CBT

First precision medicine trial in lung cancer expands to include more patients

People with sight problems could benefit from new surgical trial

Alzheimer's Association grants more than $800,000 to support the SPRINT MIND Study

NIAID-funded clinical trial of Ebola vaccines is underway at Cincinnati Children's

UTHealth enrolls first U.S. patient in novel stem cell trial to treat stroke disability

Injection of genetically modified virus effectively treats metastatic melanoma patients

Regular use of aspirin may help some patients survive head and neck cancer

NIH funds first artificial pancreas trial for pregnant women with type 1 diabetes in the U.S.

Regular use of common pain relief medicines improves survival for head and neck cancer patients

Event guide: 15th World Clinical Biomarkers & CDx Europe eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer